glp‑1 receptor agonist
70% Weight Loss With Prescription Weight Loss
70% Weight Loss With Prescription Weight Loss Prescription weight-loss drugs are not all the same; tirzepatide activates an additional appetite-control pathway that semaglutide does not, leading to deeper weight loss for many patients. Both belong to the GLP-1 receptor agonist class, but their hormonal effects diverge. Medical Disclaimer: This article